Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Harmony Gets Dissonant US FDA Response For Wakix In Idiopathic Hypersomnia
Feb 24 2025
•
By
Alaric DeArment
The FDA refused to file a supplemental NDA for Wakix in excessive daytime sleepiness in adults with IH. • Source: Shutterstock
More from Review Pathways
More from Approval Standards